As Thermo Fisher Scientific (TMO) Share Price Rose, Northstar Asset Management Has Trimmed Holding; Sp Plus (SP) Shareholder Lionstone Capital Management Has Lowered Position

February 23, 2018 - By Ellis Scott

Leon Lowenstein decreased its stake in Sp Plus Corp (SP) by 9.59% based on its latest 2017Q3 regulatory filing with the SEC. Lionstone Capital Management Llc sold 62,900 shares as the company’s stock rose 1.42% with the market. The hedge fund run by Leon Lowenstein held 592,715 shares of the rental and leasing company at the end of 2017Q3, valued at $23.41M, down from 655,615 at the end of the previous reported quarter. Lionstone Capital Management Llc who had been investing in Sp Plus Corp for a number of months, seems to be less bullish one the $802.06M market cap company. The stock increased 3.07% or $1.075 during the last trading session, reaching $36.125. About 80,165 shares traded. SP Plus Corporation (NASDAQ:SP) has risen 33.01% since February 23, 2017 and is uptrending. It has outperformed by 16.31% the S&P500.

Northstar Asset Management Llc decreased its stake in Thermo Fisher Scientific Inc. (TMO) by 6.1% based on its latest 2017Q3 regulatory filing with the SEC. Northstar Asset Management Llc sold 2,160 shares as the company’s stock rose 8.13% with the market. The institutional investor held 33,270 shares of the industrial machinery and components company at the end of 2017Q3, valued at $6.30M, down from 35,430 at the end of the previous reported quarter. Northstar Asset Management Llc who had been investing in Thermo Fisher Scientific Inc. for a number of months, seems to be less bullish one the $84.38B market cap company. The stock increased 0.62% or $1.3 during the last trading session, reaching $210.43. About 301,174 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since February 23, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Investors sentiment decreased to 1.75 in Q3 2017. Its down 1.63, from 3.38 in 2017Q2. It dropped, as 10 investors sold SP shares while 45 reduced holdings. 40 funds opened positions while 56 raised stakes. 21.50 million shares or 49.06% less from 42.21 million shares in 2017Q2 were reported. Cornercap Invest Counsel Incorporated has invested 0.13% in SP Plus Corporation (NASDAQ:SP). Hsbc Plc reported 11,951 shares stake. Comerica Bancorp holds 0.01% of its portfolio in SP Plus Corporation (NASDAQ:SP) for 48,076 shares. 42,122 are owned by State Common Retirement Fund. 1,439 were reported by Ameritas Prtnrs. Balyasny Asset Management Ltd Llc has 0% invested in SP Plus Corporation (NASDAQ:SP). Connor Clark & Lunn Mngmt owns 5,471 shares. Smith Asset Mngmt Gp Limited Partnership, a Texas-based fund reported 59,590 shares. Schwab Charles Inv reported 0.01% stake. Lord Abbett & Co Ltd Co holds 70,084 shares. Prelude Mngmt Ltd Liability Com, a New York-based fund reported 6,193 shares. 5,909 were accumulated by Zacks Investment Mngmt. Ontario – Canada-based Financial Bank Of Montreal Can has invested 0% in SP Plus Corporation (NASDAQ:SP). Suntrust Banks has 0% invested in SP Plus Corporation (NASDAQ:SP). Nuveen Asset Mgmt Ltd Llc invested in 0.16% or 605,436 shares.

Lionstone Capital Management Llc, which manages about $414.04M and $212.27M US Long portfolio, upped its stake in Cintas Corp (NASDAQ:CTAS) by 17,000 shares to 155,000 shares, valued at $22.36M in 2017Q3, according to the filing.

Among 2 analysts covering SP Plus (NASDAQ:SP), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. SP Plus had 2 analyst reports since September 4, 2015 according to SRatingsIntel. Barrington Research maintained the shares of SP in report on Monday, November 9 with “Outperform” rating. UBS maintained the stock with “Buy” rating in Friday, September 4 report.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 25. They expect $2.40 earnings per share, up 15.38% or $0.32 from last year’s $2.08 per share. TMO’s profit will be $962.38 million for 21.92 P/E if the $2.40 EPS becomes a reality. After $2.79 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -13.98% negative EPS growth.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 61 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, September 25 by Barclays Capital. The rating was maintained by Jefferies with “Hold” on Friday, October 20. Stifel Nicolaus maintained the shares of TMO in report on Monday, January 11 with “Buy” rating. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Thursday, July 23 by Mizuho. The firm earned “Hold” rating on Tuesday, August 22 by Jefferies. Evercore initiated the shares of TMO in report on Wednesday, January 3 with “Buy” rating. On Wednesday, October 11 the stock rating was maintained by Cowen & Co with “Buy”. The firm has “Buy” rating by Cleveland given on Thursday, July 20. Leerink Swann maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Friday, April 28. Leerink Swann has “Buy” rating and $187 target. As per Wednesday, January 31, the company rating was maintained by Robert W. Baird.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>